The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments

被引:0
作者
Jason S. Haukoos
Sarah E. Rowan
James W. Galbraith
Richard E. Rothman
Yu-Hsiang Hsieh
Emily Hopkins
Rachel A. Houk
Matthew F. Toerper
Kevin F. Kamis
Jake R. Morgan
Benjamin P. Linas
Alia A. Al-Tayyib
Edward M. Gardner
Michael S. Lyons
Allison L. Sabel
Douglas A. E. White
David L. Wyles
机构
[1] Denver Health Medical Center and University of Colorado School of Medicine,Department of Emergency Medicine
[2] Colorado School of Public Health,Department of Epidemiology
[3] Denver Health Medical Center and University of Colorado School of Medicine,Division of Infectious Diseases
[4] Public Health Institute at Denver Health,Department of Emergency Medicine
[5] University of Mississippi Medical Center,Department of Emergency Medicine
[6] Johns Hopkins University,Department of Informational Technology
[7] Denver Health,Department of Health Law, Policy, and Management
[8] Boston University School of Public Health,Division of Infectious Diseases
[9] Center for Health Economics of Treatment Interventions for Substance Use Disorder,Department of Emergency Medicine
[10] HCV,Center for Addiction Research
[11] and HIV,Department of Patient Safety and Quality
[12] Boston University School of Medicine,Department of Biostatistics
[13] University of Cincinnati Medical Center,Department of Emergency Medicine
[14] University of Cincinnati,undefined
[15] Denver Health,undefined
[16] Colorado School of Public Health,undefined
[17] Highland Hospital,undefined
[18] Alameda Health System,undefined
来源
Trials | / 23卷
关键词
Hepatitis C; HCV; Screening; Testing; Clinical trial; Pragmatic trial; Randomized trial; Emergency department; Prevention; Comparative effectiveness; Methods; Implementation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 75 条
  • [1] Denniston MM(2014)Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 Ann Intern Med. 160 293-300
  • [2] Jiles RB(2014)The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis PLoS One. 9 e101554-1101
  • [3] Drobeniuc J(2011)Hepatitis C virus infection in USA: an estimate of true prevalence Liver Int 31 1090-725
  • [4] Yehia BR(2015)Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1 N Engl J Med. 373 714-1603
  • [5] Schranz AJ(2014)Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin N Engl J Med. 370 1594-1493
  • [6] Umscheid CA(2014)Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection N Engl J Med. 370 1483-789
  • [7] Lo Re V(2015)The continuum of hepatitis C testing and care Hepatology. 61 783-2004
  • [8] Chak E(2019)The yield of birth cohort screening for hepatitis C in community health centers J Gen Intern Med. 34 2003-32
  • [9] Talal AH(2012)Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm Rep. 61 1-357
  • [10] Sherman KE(2013)Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement Ann Intern Med. 159 349-112